“…Furthermore, host-cell-dependent glycosylation can concentrate near epitopes that raise neutralising antibodies (Quinones-Kochs et al, 2002). E. coli has been successfully employed to produce human papillomavirus capsid protein L1 (Chen et al, 2001;Hanslip et al, 2006), VP1 and VP2 protein of chicken anemia virus (Lee et al, 2009), VP1 of murine polyomavirus (Leavitt et al, 1985;Chuan et al, 2008a), major capsid protein VP1 of simian papovavirus SV40 (Wrobel et al, 2000), capsid protein VP1 of enterovirus type 70 (Chen et al, 2004), cowpea chlorotic mottle virus coat protein (Zhao et al, 1995) and hepatitis B virus nucleocapsid protein (Wingfield et al, 1995).…”